ArticleAnimals : an open access journal from MDPI2026
Alleviating the Adverse Effects of Lipopolysaccharide on Production Performance, Immune Function, and Intestinal Damage in Broilers via Dietary Alkaline Phosphatase.
Article in Animals : an open access journal from MDPI, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this study, we investigated how adding alkaline phosphatase (ALP) to the diet improves the growth performance and intestinal function of broiler chickens under lipopolysaccharide (LPS) stress. A total of 280 one-day-old broilers were randomly allocated into four groups, each consisting of five replicates with 14 birds per replicate, and reared for 42 days. The control group and the LPS group were fed a basal diet, whereas the LPS + 1000 U/kg ALP group and the LPS + 5000 U/kg ALP group were fed the basal diet supplemented with 1000 and 5000 U/kg of ALP, respectively. Except for the control group, the other three groups were intraperitoneally injected with LPS solution at a dose of 500 μg/kg body weight at ages of 15, 17, 19, 23, 25, and 27 days. After the data were analyzed by one-way analysis of variance (ANOVA), the results showed that LPS significantly inhibited growth, disrupted intestinal structure, upregulated inflammatory genes, and downregulated tight junction protein expression, whereas dietary supplementation with 1000 U/kg ALP significantly alleviated these adverse effects, restored intestinal structure, enhanced antioxidant capacity, and modulated related gene expression. In summary, dietary ALP supplementation alleviated LPS-induced growth inhibition and intestinal damage in broilers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.